The Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine has been selected as a Cell Manufacturing Facility for the Cardiovascular Cell Therapy Research Network (CCTRN). Funded by the National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI), the Network conducts research to evaluate the use of cell-based treatment strategies for people with cardiovascular disease.
Nearly 60 patients gathered recently to celebrate the sixth anniversary of patient clinical trials at the 2014 Interdisciplinary Stem Cell Institute Patient Reunion at the University of Miami Miller School of Medicine. Joshua M. Hare, M.D., ISCI’s founding director, said patients, faculty and staff have all contributed to make a major impact in the field of regenerative medicine.
Tan A. Ince, M.D., Ph.D., associate professor of pathology and member of the University of Miami’s Sylvester Comprehensive Cancer Center, has received a $250,000 grant from the Breast Cancer Research Foundation (BCRF) to research personalized treatment of breast tumors with multi-hormone combinations.